---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-058009"
form_type: "8-K"
ticker: "CAMP"
cik: "0001736730"
company_name: "Camp4 Therapeutics Corp"
filed_at: "2025-12-18T23:59:59+00:00"
generated_at: "2026-05-16T12:45:51.406454+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# CAMP4 Therapeutics prices 5M share offering at $6.00, expects $28M net proceeds

## Summary
- CAMP4 Therapeutics priced public offering of 5,000,000 shares of common stock at $6.00 per share.
- Net proceeds expected to be approximately $28.0 million after underwriting discounts and expenses.
- Underwriting agreement with Leerink Partners LLC; closing expected on or about December 19, 2025.
- Executive officers, directors, and certain stockholders agreed to a 60-day lock-up on share sales.

## SEC filing metadata
- accession: 0001628280-25-058009
- form_type: 8-K
- ticker: CAMP
- cik: 0001736730
- company_name: Camp4 Therapeutics Corp
- filed_at: 2025-12-18T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1736730/000162828025058009/0001628280-25-058009-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1736730/000162828025058009/camp-20251218.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-058009
- JSON: https://secwatch.observer/filing/0001628280-25-058009.json
- Plain text: https://secwatch.observer/filing/0001628280-25-058009.txt

## Key facts
- Material Agreements
  Camp4 Therapeutics Corp entered into Underwriting Agreement with Leerink Partners LLC valued at Offering of 5,000,000 shares of common stock at $6.00 per share, net proceeds ~$28.0 million (effective 2025-12-18).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: Leerink Partners LLC
  - Value: Offering of 5,000,000 shares of common stock at $6.00 per share, net proceeds ~$28.0 million
  - Effective: 2025-12-18
  source text: On December 18, 2025, CAMP4 Therapeutics Corporation (the “Company”), entered into an underwriting agreement (the “ Underwriting Agreement ”) with Leerink Partners LLC (“ Leerink Partners ”), relating to an offering of 5,000,000 shares (the “ Shares ”), of its common stock, par value $0.0001 per share (the “ Common Stock ”), at an offering price of $6.00 per Share.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1736730/000162828025058009/0001628280-25-058009-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.